Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v7-EN
Language English English
Date Updated 2021-06-01 2021-04-27
Drug Identification Number 02464489 02464489
Brand name ESBRIET ESBRIET
Common or Proper name ESBRIET 267MG 270 ESBRIET 267MG 270
Company Name HOFFMANN-LA ROCHE LIMITED HOFFMANN-LA ROCHE LIMITED
Ingredients PIRFENIDONE PIRFENIDONE
Strength(s) 267MG 267MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 270 270
ATC code L04AX L04AX
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-05-10 2021-05-10
Actual start date 2021-05-10 2021-05-10
Estimated end date 2021-06-07 2021-06-07
Actual end date 2021-05-31 2021-06-07
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments 267 mg capsules or 801mg tablets (where appropriate) are an alternative and not impacted by shortage 267 mg capsules or 801mg tablets (where appropriate) are an alternative and not impacted by shortage
Health Canada comments